R. Irmisch

Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects

Peter Uwe Witte, R. Irmisch, P. Hajd� et al. · European Journal of Clinical Pharmacology · 1984 · 62 citations

Hypertension, Healthy Subjects, Cardiovascular Disease +7

Influence of renal function on the pharmacokinetics of ramipril (HOE 498)

E. R. Debusmann, Joan Ocón Pujadas, W. Lahn et al. · The American Journal of Cardiology · 1987 · 37 citations

Renal Function, Pharmacological Study, Medicine +7

Pharmacokinetics of ramipril in the elderly

Bernhardt Meyer, F. O. Müller, Mario Badian et al. · The American Journal of Cardiology · 1987 · 24 citations

Pharmacological Study, Geriatrics, Medicine +4

Steady-State Kinetics of Ramipril in Renal Failure

Heribert Schunkert, Jochen Kindler, Martin Gassmann et al. · Journal of Cardiovascular Pharmacology · 1989 · 23 citations

Tolerance and pharmacodynamics of the angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in healthy volunteers.

Witte Pu, H. Metzger, Eckert Hg et al. · PubMed · 1984 · 21 citations

Hypertension, Plasma Ace, Cardiovascular Pharmacology +20